| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 410 |
| 1 | INFLIXIMAB | 386 |
| 2 | METHOTREXATE SODIUM | 278 |
| 3 | TACROLIMUS | 275 |
| 4 | METHOTREXATE | 263 |
| 5 | ADALIMUMAB | 249 |
| 6 | MYCOPHENOLATE MOFETIL | 246 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 246 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 244 |
| 9 | TACROLIMUS OINTMENT 0.1% | 244 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE ACETATE, IODOQUINOL | 1 | 0.0303 |
| 1 | SENNOSIDES, STIMULANT LAXATIVE | 1 | 0.0139 |
| 2 | ITRACONAZOLE | 112 | 0.0095 |
| 3 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 4 | CEFOTETAN | 1 | 0.0075 |
| 5 | LANOLIN, PETROLATUM | 1 | 0.0040 |
| 6 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 7 | FIDAXOMICIN | 9 | 0.0037 |
| 8 | AMPHOTERICIN B | 40 | 0.0031 |
| 9 | NITAZOXANIDE | 1 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 550 |
| 1 | Corticosteroid [EPC] | 547 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 263 |
| 3 | Azole Antifungal [EPC] | 163 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 96 |
| 5 | Purine Antimetabolite [EPC] | 92 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 90 |
| 7 | Vitamin C [EPC] | 77 |
| 8 | Vitamin B12 [EPC] | 66 |
| 9 | Vitamin D [EPC] | 64 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 9 | 0.0089 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 42 | 0.0033 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 55 | 0.0026 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 9 | 0.0019 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 11 | 0.0019 |
| 5 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 34 | 0.0014 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 8 | Polyene Antifungal [EPC] | 52 | 0.0013 |
| 9 | Provitamin D2 Compound [EPC] | 38 | 0.0013 |